Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome
Crossref DOI link: https://doi.org/10.1007/s12471-017-1023-y
Published Online: 2017-07-31
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
ten Berg, J. M.
Zwart, B.
van ’t Hof, A. W. J.
Liem, A.
Waltenberger, J.
de Winter, R. J.
Jukema, J. W.
License valid from 2017-07-31